Advertisement
Research Article

IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis

  • Lathika Mohanraj equal contributor,

    equal contributor Contributed equally to this work with: Lathika Mohanraj, Ho-Seong Kim, Wei Li

    Affiliation: Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, United States of America

    X
  • Ho-Seong Kim equal contributor,

    equal contributor Contributed equally to this work with: Lathika Mohanraj, Ho-Seong Kim, Wei Li

    Affiliation: Department of Pediatrics, Institute of Endocrinology, Yonsei University College of Medicine, Seoul, Korea

    X
  • Wei Li equal contributor,

    equal contributor Contributed equally to this work with: Lathika Mohanraj, Ho-Seong Kim, Wei Li

    Affiliation: Biocure Pharma LLC, Richmond, Virginia, United States of America

    X
  • Qing Cai,

    Affiliation: Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, United States of America

    X
  • Ki Eun Kim,

    Affiliation: Department of Pediatrics, CHA University College of Medicine, Seoul, Korea

    X
  • Hye-Jung Shin,

    Affiliation: Department of Pediatrics, National Medical Center, Seoul, Korea

    X
  • Yong-Jae Lee,

    Affiliation: Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea

    X
  • Woo Jung Lee,

    Affiliation: Department of Pediatrics, Institute of Endocrinology, Yonsei University College of Medicine, Seoul, Korea

    X
  • Jung Hyun Kim,

    Affiliation: Department of Pediatrics, Institute of Endocrinology, Yonsei University College of Medicine, Seoul, Korea

    X
  • Youngman Oh mail

    yoh@mcvh-vcu.edu

    Affiliations: Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, United States of America, Biocure Pharma LLC, Richmond, Virginia, United States of America

    X
  • Published: January 28, 2013
  • DOI: 10.1371/journal.pone.0055084

Reader Comments (0)

Post a new comment on this article